Annexon (ANNX) Schedule 13G/A: Logos Global Reports 0 Shares
Annexon, Inc. Schedule 13G/A (Amendment No. 1) discloses that Logos Global entities and William Arsani filed jointly regarding Annexon common stock (CUSIP 03589W102) related to a reportable event dated 06/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Annexon, Inc. Schedule 13G/A (Amendment No. 1) discloses that Logos Global entities and William Arsani filed jointly regarding Annexon common stock (CUSIP 03589W102) related to a reportable event dated 06/30/2025. The filing identifies five reporting persons: Logos Global Management LP, Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, and Arsani William, and provides the filer address at One Letterman Drive, Building C, Suite C3-350, San Francisco, CA 94129.
The statement states each reporting person beneficially owns 0 shares representing 0% of the class, with zero sole or shared voting or dispositive power. The reporting persons say they file jointly but disclaim membership in a group and disclaim beneficial ownership except to the extent of any pecuniary interest. The filing is signed by Arsani William on 08/13/2025.
Insights
TL;DR: This Schedule 13G/A reports no beneficial ownership by Logos Global parties in Annexon, so no change in ownership stake is disclosed.
The filing is procedural and reports 0 shares (0%) beneficially owned by Logos Global Management LP, Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, and Arsani William. The report clarifies organizational relationships and expressly disclaims group status and beneficial ownership beyond pecuniary interest. For investors, this filing does not indicate an active stake or influence attempt; it documents ownership status and adviser/fund relationships.
TL;DR: Formal disclosure confirms advisor/fund relationships and an explicit disclaimer of beneficial ownership and group membership.
The statement provides clear governance disclosures: Logos Global acts as an investment adviser to funds, Logos Global GP and Logos GP serve as general partners, and Dr. William is identified as a control person of those entities. The filing’s joint submission with explicit disclaimers and the certification language indicates a compliance-focused document rather than a strategic ownership disclosure. Signatures dated 08/13/2025 complete the filing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A filed for Annexon (ANNX) report?
Who are the reporting persons listed on the Annexon (ANNX) Schedule 13G/A?
When is the event date and when was the Schedule 13G/A signed?
Does the filing indicate the reporters are acting as a group for Annexon (ANNX)?
Where is the principal business address of the filer listed in the Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.